Lista de obras - Upal Roy - Dominio Público Uruguay

Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.

artículo científico publicado en 2010

Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India

artículo científico publicado en 2005

Biodiversity of organotin resistant Pseudomonas from west coast of India

artículo científico publicado en 2006

Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.

artículo científico publicado en 2018

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.

artículo científico publicado en 2011

Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV-1 infected monocytic cells.

artículo científico publicado en 2013

DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine

artículo científico publicado en 2015

Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.

artículo científico publicado en 2014

Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

article

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

artículo científico publicado en 2012

MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells

artículo científico publicado en 2008

Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers

artículo científico publicado en 2016

Magnetoliposomes in Controlled-Release Drug Delivery Systems

scientific article published on 01 January 2019

Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection

artículo científico publicado en 2011

Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.

artículo científico publicado en 2010

Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides

artículo científico publicado en 2015

Molecular and phylogenetic analysis of a novel family of fibrinogen-related proteins from mosquito Aedes albopictus cell line.

artículo científico publicado en 2008

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

artículo científico publicado en 2012

Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir

artículo científico publicado en 2009

Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.

artículo científico publicado en 2012

Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy

artículo científico publicado en 2013

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.

artículo científico publicado en 2015

Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections

artículo científico publicado en 2015

Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir

artículo científico publicado en 2013

The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley

scientific article published on 01 January 2019

The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral Drugs

scientific article published on 28 February 2019

The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials

artículo científico publicado en 2015

UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues

artículo científico publicado en 2011

Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro

artículo científico publicado en 2008

Lista de obras de Upal Roy

Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages.

Antimicrobial activity of marine bacteria associated with sponges from the waters off the coast of South East India

Biodiversity of organotin resistant Pseudomonas from west coast of India

Characterization of Nanodiamond-based anti-HIV drug Delivery to the Brain.

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations.

Cycloviolacin O2 (CyO2) suppresses productive infection and augments the antiviral efficacy of nelfinavir in HIV-1 infected monocytic cells.

DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine

Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.

Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load

Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice.

MRP (ABCC) transporters-mediated efflux of anti-HIV drugs, saquinavir and zidovudine, from human endothelial cells

Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers

Magnetoliposomes in Controlled-Release Drug Delivery Systems

Mesenchymal stem cell derived hematopoietic cells are permissive to HIV-1 infection

Methods development for blood borne macrophage carriage of nanoformulated antiretroviral drugs.

Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides

Molecular and phylogenetic analysis of a novel family of fibrinogen-related proteins from mosquito Aedes albopictus cell line.

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

Montelukast is a potent and durable inhibitor of multidrug resistance protein 2-mediated efflux of taxol and saquinavir

Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1-infected human peripheral blood lymphocyte-reconstituted mice.

Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy

Preparation and characterization of anti-HIV nanodrug targeted to microfold cell of gut-associated lymphoid tissue.

Role of MRP transporters in regulating antimicrobial drug inefficacy and oxidative stress-induced pathogenesis during HIV-1 and TB infections

Specific increase in MDR1 mediated drug-efflux in human brain endothelial cells following co-exposure to HIV-1 and saquinavir

The Increase of HIV-1 Infection, Neurocognitive Impairment, and Type 2 Diabetes in The Rio Grande Valley

The Membrane-Active Phytopeptide Cycloviolacin O2 Simultaneously Targets HIV-1-infected Cells and Infectious Viral Particles to Potentiate the Efficacy of Antiretroviral Drugs

The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials

UPLC-MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues

Upregulation of HTLV-1 and HTLV-2 expression by HIV-1 in vitro